Prevalence and Incidence of Hypertension and Type 2 Diabetes in the Philippines
Hypertension Burden in the Philippines
The prevalence of hypertension in the Philippines has dramatically increased from 22% in 1993 to 37% in 2021, affecting more than one-third of the adult population, with alarmingly low awareness (52%) and control rates (37%). 1, 2
Current Prevalence Data
Overall adult prevalence: The most recent PRESYON-4 survey (2021) documented hypertension prevalence at 37%, representing a steady increase from 22% in 1993 and 25.15% in 2013 1, 2
Older adult population: Among Filipinos aged 60 years and older, the prevalence reaches 69.1%, indicating that more than two-thirds of elderly Filipinos have hypertension 3
Age-specific patterns: Hypertension prevalence increases dramatically with age, from approximately 9% in those aged 30-39 years to over 82% in those aged 70-79 years 4
Awareness, Treatment, and Control Gaps
The management cascade reveals critical gaps in hypertension care:
Awareness: Only 52% of hypertensive Filipinos are aware of their diagnosis, meaning nearly half remain undiagnosed 2
Among older adults: Awareness is slightly better at 61.6%, but still leaves 38.4% unaware of their condition 3
Treatment rates: While 68% of those aware receive treatment nationally, 51.5% of older adults with hypertension remain untreated 3, 2
Control rates: Only 37% of treated hypertensive patients achieve blood pressure control (defined as <140/90 mmHg per Philippine guidelines), and among older adults, control rates are even lower at 21.7% 1, 3, 2
Adherence: Among those treated, adherence is relatively high at 86%, suggesting the problem lies more in diagnosis and treatment initiation than medication compliance 2
Clinical Complications
The most prevalent complications of uncontrolled hypertension in the Philippines are:
- Stroke: 11.6% of hypertensive patients develop stroke, making it the leading complication 1
- Ischemic heart disease: 7.7% prevalence among hypertensive Filipinos 1
- Chronic kidney disease: 6.30% prevalence 1
- Hypertensive retinopathy: 2.30% prevalence 1
Treatment Patterns and Challenges
Monotherapy predominance: More than 80% of Filipino hypertensive patients receive monotherapy, which likely explains the persistently low control rates, as combination therapy is generally more effective for achieving target blood pressure 1
Economic burden: Hospitalization costs from hypertensive complications can deplete middle-class family savings and are catastrophic for lower-income Filipinos, creating significant barriers to care 1
Sociodemographic Factors
Age, sex, education level, and living arrangements significantly influence hypertension prevalence, awareness, treatment initiation, and blood pressure control among Filipino populations 3
Type 2 Diabetes in the Philippines
While specific national prevalence data for type 2 diabetes in the Philippines is not provided in the available evidence, the global context suggests significant burden, particularly given the high rates of obesity and metabolic syndrome risk factors in the Filipino population.
Indirect Evidence and Risk Factors
Obesity prevalence: 60.4% of hypertensive Filipinos have a BMI ≥25, indicating substantial overweight/obesity that increases diabetes risk 5
Glucose abnormalities: Among hypertensive Filipino immigrants, 12.0% had at-risk glucose measurements, suggesting undiagnosed prediabetes or diabetes 5
Metabolic syndrome clustering: The high prevalence of hypertension combined with obesity creates a population at elevated risk for type 2 diabetes, as these conditions frequently co-occur 6
Global Context for Filipino Populations
Among Filipino Americans, there is evidence of elevated cardiovascular risk factor clustering that typically includes diabetes, though specific prevalence rates for the Philippines itself require additional epidemiological data 5, 4
Clinical Implications
The Philippine healthcare system faces a critical challenge: with only 37% of hypertensive patients achieving blood pressure control and nearly half unaware of their diagnosis, urgent public health interventions are needed to prevent the devastating cardiovascular, renal, and cerebrovascular complications that result from uncontrolled hypertension. 1, 2
Key Priorities
Screening intensification: Given that 48% of hypertensive Filipinos are unaware of their condition, systematic screening programs targeting adults beginning at age 30 are essential 2
Treatment optimization: The predominance of monotherapy (>80%) despite poor control rates indicates need for earlier combination therapy initiation 1
Socioeconomic considerations: The catastrophic financial impact of hypertensive complications on Filipino families necessitates improved access to affordable preventive care and medications 1